BioNxt Solutions Inc

NEW
XTER:BXT (Canada)   Ordinary Shares
€ 0.18 -0.018 (-9.27%) Aug 12
At Loss
Market Cap:
€ 25.40M ($ 29.29M)
Enterprise V:
€ 29.32M ($ 33.80M)
Volume:
4.16K
Avg Vol (2M):
22.27K
Trade In:

Business Description

BioNxt Solutions Inc
NAICS : 325410 SIC : 3799
ISIN : CA0909741062

Share Class Description:

XTER:BXT: Ordinary Shares

Total Employee Number:

25
Description
BioNxt Solutions Inc is is a bioscience innovator focused on next-generation drug delivery systems. With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, focused on European markets. The company is committed to improving healthcare by delivering precise, patient-centric solutions that enhance treatment outcomes. Its pipeline includes BNT23001, BNT23002, BNT24002, BNT24003, BNT24004. Its geographic areas are Austria, Germany, Switzerland regions.
Name Current Vs Industry Vs History
Equity-to-Asset
-21.91
Debt-to-Equity
-0.86
Debt-to-EBITDA
-0.8
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
29
3-Year EPS without NRI Growth Rate
10
3-Year FCF Growth Rate
15.9
3-Year Book Growth Rate
-19.1
Name Current Vs Industry Vs History
5-Day RSI
30.98
9-Day RSI
39.05
14-Day RSI
42.23
3-1 Month Momentum %
-29.04
6-1 Month Momentum %
-51.63
12-1 Month Momentum %
-68.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.01
Quick Ratio
0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-10.3
Shareholder Yield %
-3.74

Profitability Rank

Name Current Vs Industry Vs History
ROA %
-1229.11
ROIC %
-204.1
3-Year ROIIC %
-9.56
ROC (Joel Greenblatt) %
-2835.36
Moat Score
3
Tariff Resilience Score
5
Name Current Vs Industry Vs History
EV-to-EBIT
-5.93
EV-to-EBITDA
-5.95
EV-to-FCF
-10.54
Earnings Yield (Greenblatt) %
-16.86
FCF Yield %
-10.95

Financials

XTER:BXT's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

BioNxt Solutions Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.043
Beta 2.2037
3-Year Sharpe Ratio 0.16
3-Year Sortino Ratio 0.31
Volatility % 67.07
14-Day RSI 42.23
14-Day ATR (€) 0.030984
20-Day SMA (€) 0.2045
12-1 Month Momentum % -68.57
52-Week Range (€) 0.17 - 0.676
Shares Outstanding (Mil) 136.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioNxt Solutions Inc Filings

Filing Date Document Date Form
No Filing Data

BioNxt Solutions Inc Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

BioNxt Solutions Inc Frequently Asked Questions

What is BioNxt Solutions Inc(XTER:BXT)'s stock price today?
The current price of XTER:BXT is €0.18. The 52 week high of XTER:BXT is €0.68 and 52 week low is €0.17.
When is next earnings date of BioNxt Solutions Inc(XTER:BXT)?
The next earnings date of BioNxt Solutions Inc(XTER:BXT) is .
Does BioNxt Solutions Inc(XTER:BXT) pay dividends? If so, how much?
BioNxt Solutions Inc(XTER:BXT) does not pay dividend.

Articles on BioNxt Solutions Inc

No articles.